Tag: CATALYST

Zimbabwe Launches Stage 2 of CATALYST Study, Adding Injectable PrEP to HIV Prevention Options for Participants

Michael Gwarisa

By Michael Gwarisa Following the delivery of injectable Pre-Exposure Prophylaxis (PrEP) doses, Zimbabwe through the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) consortium, has launched stage 2 of the CATALYST study, introducing the newly approved injectable PrEP. The study is funded by funded by PEPFER through USAID. The CATALYST study was initially launched in 2023 where two PrEP methods — tenofovir-based oral pills and the dapivirine ring (PrEP ring) — were offered. The CATALYST sites remain the same six sites where stage 1 was conducted. These include…

Read More

Zimbabwe’s Top 10 Exceptional Public Health Interventions and Innovations For 2023

Healthtimes

Even though Zimbabwe’s healthcare sector is facing challenges, there remains some extraordinary work that the Ministry of Health and Child Care (MoHCC), development partners, Civil Society Organisations (CSOs) and individuals are doing to enhance the quality care and services in Zimbabwe’s healthcare sector. Zimbabwe just like the rest of the world, is recovering from the effects of COVID-19, which to a greater extent disrupted public health interventions such as National Immunisation programs, vaccinations, and health promotion amongst a host of other interventions. Despite these challenges, Zimbabwe has innovated and come…

Read More

CATALYST Study To Inform National Scale-Up Of PrEP Products in Zimbabwe

Michael Gwarisa

By Michael Gwarisa Following the approval for the use of three Pre-Exposure Prophylaxes (PrEP) products for HIV prevention by the Zimbabwean government,  the country is conducting a three-year study to evaluate and inform the national HIV response’s rollout of PrEP products. The study named CATALYST, which stands for Catalyzing Access to New Prevention Product to Stop HIV is a multi-country study that will characterise and assess the implementation of an enhanced service delivery package providing informed choice of PrEP products among women at the sites where the study is being…

Read More

CATALYST HIV Research Study Launched In Zimbabwe

Michael Gwarisa

THE Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) consortium, has launched CATALYST, a research study that evaluates delivery of HIV prevention methods in women and girls at greater risk oF new HIV infections. By Michael Gwarisa The three-year, multi-country implementation study builds on decades of research related to pre-exposure prophylaxis (PrEP) for HIV prevention and is aimed at assessing the delivery of multiple PrEP methods to women in real-world settings in five African countries, including Zimbabwe. The study will deliver choice among three PrEP methods — daily…

Read More